IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 141 filers reported holding IMMUNOGEN INC in Q3 2014. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $225,000 | -41.1% | 36,883 | +2.2% | 0.00% | -42.9% |
| Q3 2014 | $382,000 | +4.9% | 36,080 | +17.2% | 0.01% | 0.0% |
| Q2 2014 | $364,000 | -12.9% | 30,778 | +10.1% | 0.01% | -12.5% |
| Q1 2014 | $418,000 | +32.7% | 27,954 | +29.1% | 0.01% | +60.0% |
| Q4 2013 | $315,000 | -4.5% | 21,659 | +11.1% | 0.01% | -16.7% |
| Q3 2013 | $330,000 | +44.7% | 19,495 | +41.9% | 0.01% | +20.0% |
| Q2 2013 | $228,000 | – | 13,739 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |